Kevin joined Rheos as Vice President, Finance with over 15 years of biotechnology finance and accounting experience. Prior to Rheos, he spent 11 years at Acceleron Pharma most recently serving as the company’s Vice President and Corporate Controller. During his time at Acceleron, the company completed a successful initial public offering and raised over $900 million in private and public financings. Prior to Acceleron, he spent four years at Biogen Idec in various corporate accounting and manufacturing financial planning and analysis roles.
Kevin earned a B.S. in Business from Babson College.